 Shawn St Peter
Concepts (909)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 97 | 2021 | 217 | 25.290 |
Why?
| | Appendicitis | 55 | 2020 | 118 | 20.210 |
Why?
| | Appendectomy | 46 | 2020 | 101 | 17.140 |
Why?
| | Humans | 367 | 2021 | 5654 | 14.020 |
Why?
| | Retrospective Studies | 196 | 2021 | 953 | 13.110 |
Why?
| | Male | 236 | 2021 | 3212 | 11.540 |
Why?
| | Child | 223 | 2021 | 2466 | 11.250 |
Why?
| | Female | 233 | 2020 | 3292 | 11.080 |
Why?
| | Postoperative Complications | 59 | 2020 | 150 | 10.460 |
Why?
| | Funnel Chest | 20 | 2019 | 49 | 8.950 |
Why?
| | Child, Preschool | 125 | 2020 | 1443 | 7.930 |
Why?
| | Fundoplication | 21 | 2020 | 37 | 7.900 |
Why?
| | Adolescent | 133 | 2021 | 1852 | 7.500 |
Why?
| | Treatment Outcome | 100 | 2021 | 586 | 7.490 |
Why?
| | Gastroesophageal Reflux | 18 | 2020 | 43 | 7.220 |
Why?
| | Wounds, Nonpenetrating | 26 | 2020 | 51 | 7.160 |
Why?
| | Pain, Postoperative | 16 | 2019 | 37 | 7.160 |
Why?
| | Abdominal Abscess | 14 | 2020 | 28 | 6.920 |
Why?
| | Infant | 115 | 2021 | 1315 | 6.910 |
Why?
| | Prospective Studies | 70 | 2020 | 439 | 6.730 |
Why?
| | Tomography, X-Ray Computed | 37 | 2019 | 106 | 6.070 |
Why?
| | Anti-Bacterial Agents | 24 | 2018 | 216 | 5.820 |
Why?
| | Analgesia, Patient-Controlled | 11 | 2019 | 20 | 5.120 |
Why?
| | Follow-Up Studies | 53 | 2020 | 297 | 4.960 |
Why?
| | Infant, Newborn | 86 | 2021 | 933 | 4.900 |
Why?
| | Thoracoscopy | 16 | 2020 | 29 | 4.610 |
Why?
| | Postoperative Care | 12 | 2020 | 27 | 4.560 |
Why?
| | Length of Stay | 45 | 2020 | 197 | 4.460 |
Why?
| | Surgical Wound Infection | 17 | 2021 | 26 | 4.400 |
Why?
| | Liver | 21 | 2020 | 153 | 4.370 |
Why?
| | Spleen | 15 | 2020 | 27 | 4.310 |
Why?
| | Cholecystectomy, Laparoscopic | 10 | 2019 | 22 | 3.900 |
Why?
| | Drainage | 15 | 2020 | 37 | 3.840 |
Why?
| | Enteral Nutrition | 13 | 2020 | 53 | 3.550 |
Why?
| | Esophagus | 11 | 2019 | 31 | 3.520 |
Why?
| | Pyloric Stenosis, Hypertrophic | 7 | 2016 | 9 | 3.400 |
Why?
| | Hernias, Diaphragmatic, Congenital | 10 | 2016 | 21 | 3.390 |
Why?
| | Gastrostomy | 12 | 2020 | 58 | 3.380 |
Why?
| | Minimally Invasive Surgical Procedures | 15 | 2019 | 33 | 3.350 |
Why?
| | Hernia, Inguinal | 12 | 2021 | 24 | 3.290 |
Why?
| | Esophageal Atresia | 13 | 2020 | 36 | 3.120 |
Why?
| | Randomized Controlled Trials as Topic | 11 | 2017 | 82 | 2.940 |
Why?
| | Tracheoesophageal Fistula | 10 | 2020 | 31 | 2.930 |
Why?
| | Practice Patterns, Physicians' | 11 | 2019 | 89 | 2.810 |
Why?
| | Intussusception | 7 | 2020 | 15 | 2.800 |
Why?
| | Foreign Bodies | 7 | 2018 | 18 | 2.760 |
Why?
| | Empyema, Pleural | 5 | 2020 | 7 | 2.740 |
Why?
| | Ceftriaxone | 7 | 2015 | 16 | 2.680 |
Why?
| | Pyloric Stenosis | 6 | 2016 | 12 | 2.660 |
Why?
| | Time Factors | 30 | 2019 | 289 | 2.640 |
Why?
| | Digestive System Surgical Procedures | 11 | 2019 | 38 | 2.570 |
Why?
| | Abdominal Injuries | 12 | 2019 | 21 | 2.570 |
Why?
| | Tissue Plasminogen Activator | 4 | 2020 | 5 | 2.470 |
Why?
| | Gastroschisis | 9 | 2021 | 23 | 2.410 |
Why?
| | Pediatrics | 17 | 2019 | 218 | 2.350 |
Why?
| | Herniorrhaphy | 9 | 2021 | 20 | 2.330 |
Why?
| | Anesthesia, Epidural | 4 | 2015 | 6 | 2.270 |
Why?
| | Surgical Mesh | 6 | 2012 | 8 | 2.180 |
Why?
| | Sutures | 4 | 2020 | 10 | 2.110 |
Why?
| | Metronidazole | 6 | 2015 | 18 | 2.080 |
Why?
| | Crohn Disease | 4 | 2014 | 18 | 2.040 |
Why?
| | Suture Techniques | 6 | 2020 | 12 | 2.010 |
Why?
| | Catheterization, Central Venous | 6 | 2016 | 16 | 2.010 |
Why?
| | Reoperation | 18 | 2020 | 55 | 1.980 |
Why?
| | Pneumothorax | 8 | 2019 | 21 | 1.950 |
Why?
| | Abdominal Pain | 5 | 2019 | 64 | 1.940 |
Why?
| | Analgesia, Epidural | 3 | 2019 | 11 | 1.930 |
Why?
| | Hospitals, Pediatric | 13 | 2018 | 150 | 1.920 |
Why?
| | Clinical Protocols | 9 | 2018 | 38 | 1.920 |
Why?
| | Intestinal Obstruction | 8 | 2019 | 23 | 1.910 |
Why?
| | Hernia, Hiatal | 5 | 2015 | 7 | 1.910 |
Why?
| | Suction | 5 | 2015 | 9 | 1.890 |
Why?
| | General Surgery | 8 | 2016 | 22 | 1.850 |
Why?
| | Cicatrix | 3 | 2016 | 3 | 1.810 |
Why?
| | Wounds and Injuries | 4 | 2016 | 50 | 1.810 |
Why?
| | Pylorus | 7 | 2015 | 12 | 1.810 |
Why?
| | Laparotomy | 11 | 2020 | 24 | 1.790 |
Why?
| | Hernia, Diaphragmatic | 8 | 2012 | 17 | 1.780 |
Why?
| | Algorithms | 10 | 2020 | 92 | 1.720 |
Why?
| | Umbilicus | 5 | 2018 | 11 | 1.710 |
Why?
| | Peritoneal Lavage | 3 | 2015 | 6 | 1.710 |
Why?
| | Cryosurgery | 2 | 2019 | 10 | 1.660 |
Why?
| | Fibrinolytic Agents | 4 | 2015 | 5 | 1.640 |
Why?
| | Severity of Illness Index | 7 | 2018 | 142 | 1.630 |
Why?
| | United States | 29 | 2019 | 657 | 1.620 |
Why?
| | Urinary Retention | 4 | 2018 | 5 | 1.610 |
Why?
| | Specialties, Surgical | 6 | 2016 | 13 | 1.560 |
Why?
| | Ileum | 3 | 2014 | 19 | 1.550 |
Why?
| | Circumcision, Male | 2 | 2018 | 3 | 1.540 |
Why?
| | Esophagoscopy | 4 | 2016 | 8 | 1.530 |
Why?
| | Evidence-Based Medicine | 8 | 2014 | 46 | 1.530 |
Why?
| | Operative Time | 11 | 2019 | 27 | 1.520 |
Why?
| | Kidney | 5 | 2013 | 91 | 1.520 |
Why?
| | Intestinal Volvulus | 5 | 2019 | 15 | 1.520 |
Why?
| | Thoracic Surgery, Video-Assisted | 5 | 2020 | 10 | 1.510 |
Why?
| | Abscess | 5 | 2014 | 13 | 1.510 |
Why?
| | Gallbladder Diseases | 4 | 2016 | 13 | 1.500 |
Why?
| | Cryptorchidism | 3 | 2016 | 8 | 1.490 |
Why?
| | Risk Factors | 23 | 2021 | 376 | 1.480 |
Why?
| | Radiography, Thoracic | 5 | 2017 | 13 | 1.450 |
Why?
| | Quality Improvement | 6 | 2018 | 52 | 1.410 |
Why?
| | Adult | 24 | 2016 | 1065 | 1.400 |
Why?
| | Bed Rest | 5 | 2013 | 10 | 1.390 |
Why?
| | Enterocolitis, Necrotizing | 10 | 2018 | 57 | 1.390 |
Why?
| | Ileal Diseases | 3 | 2018 | 8 | 1.370 |
Why?
| | Obesity | 3 | 2012 | 91 | 1.350 |
Why?
| | Cholelithiasis | 3 | 2015 | 9 | 1.340 |
Why?
| | Hernia, Umbilical | 5 | 2019 | 9 | 1.340 |
Why?
| | Esophageal Achalasia | 2 | 2016 | 4 | 1.320 |
Why?
| | Patient Discharge | 7 | 2020 | 53 | 1.310 |
Why?
| | Pain Measurement | 7 | 2019 | 44 | 1.300 |
Why?
| | Hirschsprung Disease | 5 | 2019 | 29 | 1.290 |
Why?
| | Incidence | 27 | 2020 | 126 | 1.290 |
Why?
| | Biliary Dyskinesia | 4 | 2019 | 8 | 1.260 |
Why?
| | Recurrence | 17 | 2021 | 101 | 1.260 |
Why?
| | Blood Transfusion | 6 | 2017 | 18 | 1.250 |
Why?
| | Ribs | 2 | 2016 | 5 | 1.240 |
Why?
| | Liver Transplantation | 6 | 2004 | 29 | 1.200 |
Why?
| | Esophageal Perforation | 2 | 2017 | 4 | 1.180 |
Why?
| | Combined Modality Therapy | 11 | 2018 | 50 | 1.170 |
Why?
| | Urinary Catheterization | 4 | 2018 | 5 | 1.150 |
Why?
| | Appendix | 3 | 2018 | 10 | 1.150 |
Why?
| | Thoracic Surgical Procedures | 5 | 2011 | 10 | 1.150 |
Why?
| | Intestinal Perforation | 6 | 2018 | 11 | 1.140 |
Why?
| | Ambulatory Surgical Procedures | 5 | 2018 | 15 | 1.140 |
Why?
| | Histamine H2 Antagonists | 3 | 2017 | 10 | 1.120 |
Why?
| | Biomedical Research | 4 | 2018 | 47 | 1.110 |
Why?
| | Fluoroscopy | 6 | 2018 | 14 | 1.100 |
Why?
| | Catheterization | 4 | 2016 | 22 | 1.090 |
Why?
| | Enema | 6 | 2020 | 12 | 1.080 |
Why?
| | Stomach | 3 | 2018 | 15 | 1.080 |
Why?
| | Cecum | 2 | 2014 | 5 | 1.080 |
Why?
| | Preoperative Care | 10 | 2015 | 26 | 1.070 |
Why?
| | Unnecessary Procedures | 2 | 2020 | 14 | 1.060 |
Why?
| | Patient Satisfaction | 10 | 2019 | 42 | 1.060 |
Why?
| | Surveys and Questionnaires | 12 | 2020 | 266 | 1.040 |
Why?
| | Intestine, Small | 6 | 2014 | 19 | 1.030 |
Why?
| | Age Factors | 11 | 2015 | 227 | 1.030 |
Why?
| | Esophagoplasty | 3 | 2020 | 4 | 1.030 |
Why?
| | Clinical Trials as Topic | 4 | 2018 | 62 | 1.020 |
Why?
| | Splenectomy | 5 | 2017 | 10 | 1.020 |
Why?
| | Pancreas | 4 | 2017 | 12 | 1.010 |
Why?
| | Intubation, Gastrointestinal | 5 | 2018 | 19 | 1.000 |
Why?
| | Risk Assessment | 12 | 2019 | 151 | 0.990 |
Why?
| | Perioperative Care | 2 | 2018 | 10 | 0.980 |
Why?
| | Orthopedic Procedures | 4 | 2018 | 17 | 0.980 |
Why?
| | Databases, Factual | 6 | 2016 | 97 | 0.970 |
Why?
| | Antibiotic Prophylaxis | 7 | 2017 | 22 | 0.970 |
Why?
| | Prognosis | 15 | 2019 | 182 | 0.950 |
Why?
| | Critical Pathways | 3 | 2018 | 9 | 0.940 |
Why?
| | Colitis, Ulcerative | 2 | 2011 | 6 | 0.940 |
Why?
| | Birth Weight | 7 | 2018 | 29 | 0.940 |
Why?
| | Heart Defects, Congenital | 4 | 2018 | 59 | 0.940 |
Why?
| | Pneumoperitoneum, Artificial | 2 | 2011 | 7 | 0.930 |
Why?
| | Clinical Decision-Making | 2 | 2018 | 33 | 0.930 |
Why?
| | Organ Preservation | 5 | 2003 | 7 | 0.930 |
Why?
| | Respiratory Insufficiency | 3 | 2019 | 14 | 0.930 |
Why?
| | Intraoperative Care | 3 | 2018 | 6 | 0.910 |
Why?
| | Biocompatible Materials | 2 | 2012 | 3 | 0.890 |
Why?
| | Ultrasonography | 10 | 2019 | 40 | 0.890 |
Why?
| | Guideline Adherence | 1 | 2020 | 32 | 0.890 |
Why?
| | Burns | 4 | 2014 | 19 | 0.860 |
Why?
| | Sensitivity and Specificity | 10 | 2018 | 141 | 0.850 |
Why?
| | Tissue Adhesions | 2 | 2017 | 5 | 0.850 |
Why?
| | Thoracotomy | 2 | 2018 | 10 | 0.840 |
Why?
| | Medical Errors | 1 | 2019 | 9 | 0.840 |
Why?
| | Pericardium | 2 | 2011 | 6 | 0.840 |
Why?
| | Drug Therapy, Combination | 7 | 2018 | 48 | 0.810 |
Why?
| | Orchiopexy | 2 | 2015 | 5 | 0.810 |
Why?
| | Sodium Chloride | 2 | 2016 | 3 | 0.810 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 20 | 0.810 |
Why?
| | Testis | 2 | 2015 | 6 | 0.810 |
Why?
| | Hypertension, Pulmonary | 2 | 2017 | 10 | 0.810 |
Why?
| | Research Design | 2 | 2018 | 69 | 0.810 |
Why?
| | Young Adult | 9 | 2019 | 526 | 0.800 |
Why?
| | Pleural Effusion | 3 | 2016 | 5 | 0.800 |
Why?
| | Trauma Centers | 12 | 2020 | 33 | 0.800 |
Why?
| | Intercostal Nerves | 1 | 2018 | 3 | 0.800 |
Why?
| | Phimosis | 1 | 2018 | 1 | 0.800 |
Why?
| | Lung Diseases | 1 | 2018 | 35 | 0.800 |
Why?
| | Neuromuscular Diseases | 1 | 2018 | 3 | 0.790 |
Why?
| | Colonic Diseases | 3 | 2014 | 4 | 0.790 |
Why?
| | Acute Disease | 6 | 2020 | 59 | 0.780 |
Why?
| | Chest Tubes | 5 | 2020 | 13 | 0.780 |
Why?
| | Tissue Adhesives | 2 | 2017 | 3 | 0.780 |
Why?
| | Malnutrition | 1 | 2018 | 11 | 0.780 |
Why?
| | Bronchoscopy | 5 | 2016 | 8 | 0.770 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2016 | 19 | 0.770 |
Why?
| | Abnormalities, Multiple | 6 | 2018 | 34 | 0.760 |
Why?
| | Sample Size | 1 | 2017 | 4 | 0.760 |
Why?
| | Drug Administration Schedule | 7 | 2018 | 50 | 0.760 |
Why?
| | Gestational Age | 12 | 2019 | 92 | 0.760 |
Why?
| | Cyanoacrylates | 1 | 2017 | 2 | 0.760 |
Why?
| | Endoscopy, Gastrointestinal | 5 | 2019 | 18 | 0.750 |
Why?
| | Administration, Oral | 9 | 2018 | 83 | 0.750 |
Why?
| | Ranitidine | 2 | 2015 | 6 | 0.740 |
Why?
| | Esophageal pH Monitoring | 3 | 2012 | 4 | 0.730 |
Why?
| | Cohort Studies | 11 | 2018 | 231 | 0.730 |
Why?
| | Pancreatitis | 3 | 2012 | 7 | 0.720 |
Why?
| | Dissection | 2 | 2014 | 2 | 0.720 |
Why?
| | Pulmonary Emphysema | 2 | 2019 | 4 | 0.710 |
Why?
| | Device Removal | 4 | 2014 | 13 | 0.710 |
Why?
| | Cartilage Diseases | 1 | 2016 | 3 | 0.710 |
Why?
| | Costal Cartilage | 1 | 2016 | 3 | 0.710 |
Why?
| | Joint Diseases | 1 | 2016 | 4 | 0.710 |
Why?
| | Injury Severity Score | 11 | 2019 | 50 | 0.700 |
Why?
| | Fever | 2 | 2014 | 29 | 0.700 |
Why?
| | Health Resources | 2 | 2014 | 21 | 0.700 |
Why?
| | Pilonidal Sinus | 2 | 2019 | 4 | 0.690 |
Why?
| | Diagnosis, Differential | 9 | 2018 | 69 | 0.690 |
Why?
| | Proctocolectomy, Restorative | 2 | 2020 | 4 | 0.690 |
Why?
| | Patient Readmission | 7 | 2020 | 63 | 0.690 |
Why?
| | Radiography, Interventional | 1 | 2016 | 1 | 0.680 |
Why?
| | Refusal to Participate | 1 | 2016 | 2 | 0.680 |
Why?
| | Fluid Therapy | 1 | 2016 | 5 | 0.680 |
Why?
| | Rectum | 5 | 2019 | 16 | 0.670 |
Why?
| | High-Frequency Ventilation | 2 | 2016 | 7 | 0.670 |
Why?
| | Emergency Service, Hospital | 6 | 2020 | 113 | 0.670 |
Why?
| | Pancreatectomy | 2 | 2013 | 3 | 0.670 |
Why?
| | Body Mass Index | 7 | 2016 | 111 | 0.670 |
Why?
| | Hospital Costs | 3 | 2016 | 23 | 0.670 |
Why?
| | Quality of Life | 2 | 2020 | 97 | 0.660 |
Why?
| | Nervous System Diseases | 2 | 2014 | 17 | 0.660 |
Why?
| | Overweight | 3 | 2014 | 32 | 0.650 |
Why?
| | Intestinal Atresia | 3 | 2010 | 12 | 0.650 |
Why?
| | Cost-Benefit Analysis | 6 | 2016 | 40 | 0.640 |
Why?
| | Dilatation | 1 | 2015 | 1 | 0.630 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2015 | 1 | 0.630 |
Why?
| | Gastric Fistula | 1 | 2015 | 3 | 0.630 |
Why?
| | Cutaneous Fistula | 1 | 2015 | 3 | 0.630 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 18 | 0.630 |
Why?
| | Proton Pump Inhibitors | 1 | 2015 | 12 | 0.620 |
Why?
| | Gallstones | 2 | 2012 | 3 | 0.620 |
Why?
| | Predictive Value of Tests | 7 | 2019 | 100 | 0.610 |
Why?
| | Anastomosis, Surgical | 5 | 2010 | 14 | 0.610 |
Why?
| | Ileostomy | 2 | 2011 | 4 | 0.610 |
Why?
| | Apnea | 2 | 2012 | 6 | 0.600 |
Why?
| | Treatment Failure | 7 | 2019 | 19 | 0.600 |
Why?
| | Neutropenia | 2 | 2011 | 14 | 0.600 |
Why?
| | Vascular Access Devices | 1 | 2014 | 1 | 0.590 |
Why?
| | Needles | 1 | 2014 | 2 | 0.590 |
Why?
| | Thoracostomy | 3 | 2014 | 5 | 0.590 |
Why?
| | Equipment Failure | 1 | 2014 | 8 | 0.590 |
Why?
| | Prosthesis Implantation | 2 | 2010 | 4 | 0.570 |
Why?
| | Respiratory Aspiration | 1 | 2013 | 1 | 0.570 |
Why?
| | Postoperative Period | 7 | 2018 | 16 | 0.570 |
Why?
| | Pain Threshold | 1 | 2013 | 4 | 0.570 |
Why?
| | Diagnostic Self Evaluation | 1 | 2013 | 1 | 0.560 |
Why?
| | Diaphragm | 2 | 2010 | 6 | 0.560 |
Why?
| | Debridement | 2 | 2012 | 6 | 0.560 |
Why?
| | Contrast Media | 3 | 2014 | 18 | 0.560 |
Why?
| | Postoperative Nausea and Vomiting | 2 | 2013 | 5 | 0.550 |
Why?
| | Venous Thrombosis | 1 | 2013 | 1 | 0.550 |
Why?
| | Elective Surgical Procedures | 4 | 2018 | 15 | 0.540 |
Why?
| | Radiography | 7 | 2015 | 38 | 0.540 |
Why?
| | Tietze's Syndrome | 1 | 2012 | 1 | 0.540 |
Why?
| | Therapeutic Equipoise | 1 | 2012 | 1 | 0.540 |
Why?
| | Cartilage | 1 | 2012 | 2 | 0.540 |
Why?
| | Abdominal Wall | 3 | 2020 | 7 | 0.540 |
Why?
| | Biopsy | 6 | 2019 | 52 | 0.540 |
Why?
| | Genital Diseases, Male | 1 | 2012 | 1 | 0.530 |
Why?
| | Comorbidity | 6 | 2017 | 63 | 0.530 |
Why?
| | Hemangioma | 1 | 2012 | 1 | 0.530 |
Why?
| | Splenic Neoplasms | 1 | 2012 | 2 | 0.530 |
Why?
| | Internship and Residency | 3 | 2013 | 35 | 0.530 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2012 | 3 | 0.530 |
Why?
| | Silver Sulfadiazine | 1 | 2012 | 5 | 0.520 |
Why?
| | Collagenases | 1 | 2012 | 7 | 0.520 |
Why?
| | Ovarian Cysts | 1 | 2012 | 2 | 0.520 |
Why?
| | Societies, Medical | 5 | 2017 | 39 | 0.520 |
Why?
| | Analgesics, Opioid | 4 | 2018 | 38 | 0.520 |
Why?
| | Middle Aged | 8 | 2016 | 561 | 0.520 |
Why?
| | Cystadenoma, Mucinous | 1 | 2012 | 1 | 0.510 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 7 | 0.510 |
Why?
| | Heart Injuries | 1 | 2011 | 4 | 0.510 |
Why?
| | Monitoring, Physiologic | 1 | 2012 | 21 | 0.500 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2011 | 1 | 0.500 |
Why?
| | Insufflation | 1 | 2011 | 3 | 0.500 |
Why?
| | Single-Blind Method | 4 | 2018 | 15 | 0.500 |
Why?
| | Anticoagulants | 2 | 2013 | 17 | 0.500 |
Why?
| | Adrenalectomy | 1 | 2011 | 2 | 0.500 |
Why?
| | Thorax | 1 | 2011 | 4 | 0.480 |
Why?
| | Sports Equipment | 1 | 2011 | 2 | 0.480 |
Why?
| | Colectomy | 1 | 2011 | 10 | 0.480 |
Why?
| | Decision Making | 1 | 2013 | 97 | 0.480 |
Why?
| | Accidents, Home | 1 | 2011 | 9 | 0.470 |
Why?
| | Iatrogenic Disease | 2 | 2010 | 6 | 0.470 |
Why?
| | Ossification, Heterotopic | 1 | 2010 | 2 | 0.470 |
Why?
| | Thymoma | 1 | 2010 | 2 | 0.470 |
Why?
| | Thymus Neoplasms | 1 | 2010 | 2 | 0.470 |
Why?
| | Jejunal Diseases | 1 | 2010 | 3 | 0.460 |
Why?
| | Therapeutic Irrigation | 3 | 2016 | 5 | 0.460 |
Why?
| | Periodicity | 1 | 2010 | 3 | 0.460 |
Why?
| | Duodenal Diseases | 1 | 2010 | 5 | 0.460 |
Why?
| | Fecal Incontinence | 3 | 2020 | 15 | 0.460 |
Why?
| | Decompression, Surgical | 1 | 2010 | 4 | 0.460 |
Why?
| | Reproducibility of Results | 8 | 2018 | 176 | 0.460 |
Why?
| | Nutritional Support | 1 | 2010 | 4 | 0.460 |
Why?
| | Xiphoid Bone | 1 | 2010 | 6 | 0.460 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2010 | 23 | 0.450 |
Why?
| | Laparoscopes | 1 | 2010 | 1 | 0.450 |
Why?
| | Histamine H1 Antagonists | 1 | 2010 | 3 | 0.450 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 4 | 2018 | 5 | 0.440 |
Why?
| | Digestive System Abnormalities | 2 | 2009 | 8 | 0.440 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 5 | 0.440 |
Why?
| | Bezoars | 1 | 2009 | 3 | 0.440 |
Why?
| | Empyema | 2 | 2009 | 3 | 0.440 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2009 | 7 | 0.430 |
Why?
| | Ileocecal Valve | 1 | 2009 | 4 | 0.430 |
Why?
| | Intestinal Mucosa | 3 | 2019 | 33 | 0.430 |
Why?
| | Colon | 3 | 2015 | 12 | 0.430 |
Why?
| | Hemostatics | 1 | 2009 | 2 | 0.420 |
Why?
| | Thrombin | 1 | 2009 | 2 | 0.420 |
Why?
| | Wounds, Stab | 1 | 2009 | 2 | 0.420 |
Why?
| | Tibial Arteries | 1 | 2009 | 2 | 0.420 |
Why?
| | Ultrasonography, Interventional | 1 | 2009 | 4 | 0.420 |
Why?
| | Aneurysm, False | 1 | 2009 | 3 | 0.420 |
Why?
| | Thrombolytic Therapy | 1 | 2009 | 2 | 0.420 |
Why?
| | Cholecystitis | 2 | 2008 | 6 | 0.410 |
Why?
| | Lung | 3 | 2019 | 86 | 0.410 |
Why?
| | Hospitalization | 5 | 2020 | 126 | 0.410 |
Why?
| | Hypokalemia | 1 | 2008 | 1 | 0.410 |
Why?
| | Alkalosis | 1 | 2008 | 2 | 0.410 |
Why?
| | Surgical Procedures, Operative | 4 | 2014 | 15 | 0.410 |
Why?
| | Patient Selection | 3 | 2018 | 62 | 0.410 |
Why?
| | Aged | 6 | 2015 | 292 | 0.400 |
Why?
| | Regression Analysis | 4 | 2019 | 60 | 0.400 |
Why?
| | Hemorrhage | 2 | 2019 | 16 | 0.400 |
Why?
| | Anesthetics | 2 | 2021 | 4 | 0.400 |
Why?
| | Missouri | 5 | 2018 | 80 | 0.400 |
Why?
| | Abdomen | 2 | 2009 | 5 | 0.400 |
Why?
| | Workload | 1 | 2008 | 7 | 0.400 |
Why?
| | Parents | 3 | 2016 | 164 | 0.400 |
Why?
| | Gentamicins | 1 | 2008 | 6 | 0.400 |
Why?
| | Practice Guidelines as Topic | 4 | 2018 | 102 | 0.400 |
Why?
| | Medical Staff, Hospital | 1 | 2008 | 10 | 0.390 |
Why?
| | Trauma Severity Indices | 4 | 2013 | 16 | 0.390 |
Why?
| | Patient Care Team | 1 | 2008 | 25 | 0.390 |
Why?
| | Anesthesia, Intravenous | 1 | 2008 | 1 | 0.390 |
Why?
| | Splenic Rupture | 1 | 2008 | 2 | 0.390 |
Why?
| | Milk, Human | 3 | 2019 | 21 | 0.390 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 55 | 0.390 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2020 | 38 | 0.390 |
Why?
| | Cholecystectomy | 3 | 2013 | 10 | 0.380 |
Why?
| | Duodenal Obstruction | 4 | 2008 | 8 | 0.380 |
Why?
| | Internal Fixators | 1 | 2007 | 3 | 0.380 |
Why?
| | Case-Control Studies | 5 | 2019 | 104 | 0.380 |
Why?
| | Hospital Charges | 3 | 2016 | 12 | 0.370 |
Why?
| | Antithrombin III | 1 | 2007 | 2 | 0.370 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2007 | 2 | 0.370 |
Why?
| | Hernia | 2 | 2018 | 4 | 0.370 |
Why?
| | Pain | 4 | 2020 | 46 | 0.360 |
Why?
| | Airway Obstruction | 3 | 2013 | 16 | 0.360 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2006 | 1 | 0.360 |
Why?
| | Hypertension, Renovascular | 1 | 2006 | 3 | 0.350 |
Why?
| | Vascular Surgical Procedures | 1 | 2006 | 5 | 0.350 |
Why?
| | Infant, Premature | 6 | 2019 | 138 | 0.350 |
Why?
| | Blood Vessels | 1 | 2006 | 5 | 0.350 |
Why?
| | Gastrointestinal Diseases | 2 | 2017 | 49 | 0.350 |
Why?
| | Survival Rate | 5 | 2019 | 82 | 0.350 |
Why?
| | Radiation Dosage | 3 | 2014 | 5 | 0.340 |
Why?
| | Ostomy | 2 | 2018 | 4 | 0.340 |
Why?
| | Rectal Prolapse | 2 | 2020 | 10 | 0.340 |
Why?
| | Forecasting | 2 | 2020 | 24 | 0.340 |
Why?
| | Multiple Trauma | 3 | 2013 | 13 | 0.330 |
Why?
| | Superior Mesenteric Artery Syndrome | 2 | 2020 | 5 | 0.330 |
Why?
| | Infant, Newborn, Diseases | 3 | 2018 | 36 | 0.330 |
Why?
| | Pleura | 1 | 2005 | 1 | 0.330 |
Why?
| | Intention to Treat Analysis | 2 | 2018 | 8 | 0.330 |
Why?
| | Delivery, Obstetric | 1 | 2005 | 7 | 0.330 |
Why?
| | Spherocytosis, Hereditary | 2 | 2015 | 4 | 0.320 |
Why?
| | Duodenum | 2 | 2020 | 19 | 0.320 |
Why?
| | Guidelines as Topic | 2 | 2018 | 19 | 0.320 |
Why?
| | Urinary Diversion | 1 | 2005 | 1 | 0.320 |
Why?
| | Pilot Projects | 3 | 2019 | 96 | 0.320 |
Why?
| | Gastric Bypass | 1 | 2005 | 6 | 0.320 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2011 | 23 | 0.320 |
Why?
| | Logistic Models | 3 | 2019 | 94 | 0.310 |
Why?
| | Electrolytes | 2 | 2016 | 6 | 0.310 |
Why?
| | Morbidity | 2 | 2016 | 12 | 0.310 |
Why?
| | Anemia, Sickle Cell | 2 | 2015 | 27 | 0.310 |
Why?
| | Surgical Stomas | 2 | 2018 | 5 | 0.310 |
Why?
| | Recovery of Function | 3 | 2019 | 13 | 0.310 |
Why?
| | Colorectal Surgery | 2 | 2014 | 3 | 0.310 |
Why?
| | Gastrointestinal Tract | 2 | 2018 | 7 | 0.310 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2004 | 1 | 0.310 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2004 | 3 | 0.300 |
Why?
| | Pain Management | 2 | 2015 | 20 | 0.300 |
Why?
| | ROC Curve | 2 | 2016 | 20 | 0.300 |
Why?
| | Esthetics | 3 | 2013 | 7 | 0.290 |
Why?
| | Intraoperative Complications | 2 | 2015 | 6 | 0.290 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2003 | 1 | 0.290 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 2003 | 1 | 0.290 |
Why?
| | Plastics | 2 | 2014 | 3 | 0.290 |
Why?
| | Pneumonia | 3 | 2017 | 25 | 0.290 |
Why?
| | Vomiting | 3 | 2020 | 23 | 0.290 |
Why?
| | Liver Neoplasms | 1 | 2003 | 14 | 0.290 |
Why?
| | Disease Management | 2 | 2014 | 34 | 0.280 |
Why?
| | Splenic Diseases | 2 | 2017 | 2 | 0.280 |
Why?
| | Skin Transplantation | 2 | 2014 | 7 | 0.280 |
Why?
| | Health Care Surveys | 4 | 2015 | 41 | 0.280 |
Why?
| | Liver Circulation | 1 | 2003 | 3 | 0.280 |
Why?
| | Rupture, Spontaneous | 3 | 2016 | 8 | 0.280 |
Why?
| | Registries | 3 | 2019 | 75 | 0.280 |
Why?
| | Animals | 5 | 2021 | 866 | 0.280 |
Why?
| | Infant, Premature, Diseases | 3 | 2013 | 47 | 0.280 |
Why?
| | Reperfusion | 2 | 2002 | 3 | 0.280 |
Why?
| | Lethargy | 2 | 2013 | 2 | 0.270 |
Why?
| | Age Distribution | 4 | 2013 | 37 | 0.270 |
Why?
| | Injections, Intravenous | 2 | 2015 | 23 | 0.270 |
Why?
| | Chlorides | 2 | 2016 | 3 | 0.270 |
Why?
| | Bicarbonates | 2 | 2016 | 6 | 0.270 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2014 | 18 | 0.270 |
Why?
| | Clinical Competence | 2 | 2015 | 39 | 0.270 |
Why?
| | Respiratory System Abnormalities | 2 | 2019 | 4 | 0.260 |
Why?
| | Equipment Design | 3 | 2014 | 13 | 0.260 |
Why?
| | Endoscopy | 2 | 2012 | 15 | 0.260 |
Why?
| | Tissue and Organ Procurement | 1 | 2002 | 20 | 0.260 |
Why?
| | Meckel Diverticulum | 2 | 2014 | 6 | 0.260 |
Why?
| | Surgeons | 3 | 2016 | 5 | 0.250 |
Why?
| | Anthropometry | 2 | 2012 | 22 | 0.250 |
Why?
| | Craniocerebral Trauma | 2 | 2014 | 15 | 0.250 |
Why?
| | Community-Acquired Infections | 2 | 2011 | 9 | 0.250 |
Why?
| | Pleural Diseases | 3 | 2011 | 5 | 0.240 |
Why?
| | Sepsis | 2 | 2019 | 23 | 0.240 |
Why?
| | Hypothermia | 1 | 2021 | 3 | 0.240 |
Why?
| | Anesthesia, General | 1 | 2021 | 2 | 0.240 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2018 | 3 | 0.240 |
Why?
| | Eosinophilia | 2 | 2019 | 23 | 0.240 |
Why?
| | Kidney Transplantation | 1 | 2002 | 107 | 0.240 |
Why?
| | Patient Compliance | 2 | 2019 | 77 | 0.230 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2011 | 105 | 0.230 |
Why?
| | Heart Ventricles | 2 | 2018 | 31 | 0.230 |
Why?
| | Ligaments | 1 | 2020 | 3 | 0.230 |
Why?
| | Survival Analysis | 2 | 2018 | 51 | 0.230 |
Why?
| | Wound Closure Techniques | 1 | 2020 | 2 | 0.220 |
Why?
| | Constipation | 1 | 2020 | 14 | 0.220 |
Why?
| | Cross-Over Studies | 1 | 2020 | 39 | 0.220 |
Why?
| | Fibrinolysis | 1 | 2020 | 2 | 0.220 |
Why?
| | Skin | 1 | 2020 | 16 | 0.220 |
Why?
| | Thoracentesis | 1 | 2019 | 2 | 0.220 |
Why?
| | Venous Thromboembolism | 1 | 2020 | 11 | 0.220 |
Why?
| | Probability | 3 | 2008 | 21 | 0.220 |
Why?
| | Gallbladder | 1 | 2019 | 4 | 0.220 |
Why?
| | Short Bowel Syndrome | 1 | 2019 | 4 | 0.220 |
Why?
| | Self Report | 1 | 2019 | 32 | 0.220 |
Why?
| | Manipulation, Orthopedic | 1 | 2019 | 6 | 0.210 |
Why?
| | Congenital Abnormalities | 3 | 2016 | 18 | 0.210 |
Why?
| | Braces | 1 | 2019 | 10 | 0.210 |
Why?
| | Pectus Carinatum | 1 | 2019 | 10 | 0.210 |
Why?
| | Conversion to Open Surgery | 2 | 2019 | 3 | 0.210 |
Why?
| | Sex Factors | 3 | 2014 | 76 | 0.210 |
Why?
| | Prenatal Diagnosis | 4 | 2019 | 19 | 0.210 |
Why?
| | Meconium | 2 | 2009 | 3 | 0.210 |
Why?
| | Pancreatic Pseudocyst | 2 | 2009 | 3 | 0.210 |
Why?
| | Multicenter Studies as Topic | 2 | 2016 | 10 | 0.210 |
Why?
| | Propensity Score | 1 | 2018 | 8 | 0.200 |
Why?
| | Thoracoplasty | 1 | 2018 | 1 | 0.200 |
Why?
| | Pain Perception | 1 | 2018 | 2 | 0.200 |
Why?
| | Anorexia | 1 | 2018 | 2 | 0.200 |
Why?
| | Surgical Instruments | 2 | 2010 | 4 | 0.200 |
Why?
| | Perception | 2 | 2016 | 11 | 0.200 |
Why?
| | Feasibility Studies | 2 | 2019 | 42 | 0.200 |
Why?
| | Urinary Catheters | 1 | 2018 | 1 | 0.200 |
Why?
| | Pancreatic Ducts | 1 | 2018 | 3 | 0.200 |
Why?
| | Jejunum | 1 | 2018 | 7 | 0.200 |
Why?
| | Syndrome | 2 | 2016 | 29 | 0.200 |
Why?
| | Catheters, Indwelling | 1 | 2018 | 25 | 0.200 |
Why?
| | Postoperative Hemorrhage | 1 | 2018 | 1 | 0.200 |
Why?
| | Analgesics | 1 | 2018 | 8 | 0.200 |
Why?
| | Narcotics | 1 | 2018 | 10 | 0.200 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 9 | 0.200 |
Why?
| | Attitude to Health | 1 | 2018 | 42 | 0.200 |
Why?
| | Pelvic Neoplasms | 1 | 2018 | 3 | 0.200 |
Why?
| | Organs at Risk | 1 | 2018 | 3 | 0.200 |
Why?
| | Prostheses and Implants | 2 | 2011 | 9 | 0.200 |
Why?
| | Electric Power Supplies | 1 | 2018 | 1 | 0.200 |
Why?
| | Fertility Preservation | 1 | 2018 | 6 | 0.190 |
Why?
| | Counseling | 2 | 2018 | 64 | 0.190 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2018 | 10 | 0.190 |
Why?
| | Cost of Illness | 2 | 2008 | 16 | 0.190 |
Why?
| | Acetaminophen | 1 | 2018 | 25 | 0.190 |
Why?
| | Embolization, Therapeutic | 2 | 2017 | 11 | 0.190 |
Why?
| | Blood Gas Analysis | 2 | 2011 | 9 | 0.190 |
Why?
| | Magnets | 1 | 2017 | 2 | 0.190 |
Why?
| | Complementary Therapies | 1 | 2017 | 5 | 0.190 |
Why?
| | Gastroenterology | 1 | 2017 | 12 | 0.190 |
Why?
| | Diagnostic Imaging | 1 | 2017 | 10 | 0.190 |
Why?
| | Ileitis | 1 | 2017 | 4 | 0.190 |
Why?
| | Emergency Medical Services | 1 | 2017 | 16 | 0.190 |
Why?
| | Clostridium Infections | 1 | 2017 | 7 | 0.180 |
Why?
| | Hypotension | 1 | 2017 | 4 | 0.180 |
Why?
| | Trachea | 3 | 2017 | 14 | 0.180 |
Why?
| | Decision Support Techniques | 2 | 2015 | 12 | 0.180 |
Why?
| | Academic Medical Centers | 1 | 2016 | 9 | 0.180 |
Why?
| | Body Weight | 2 | 2019 | 62 | 0.180 |
Why?
| | Program Development | 1 | 2016 | 18 | 0.180 |
Why?
| | Peritoneal Diseases | 1 | 2016 | 2 | 0.180 |
Why?
| | Shock, Traumatic | 1 | 2016 | 2 | 0.180 |
Why?
| | Infant Formula | 2 | 2013 | 13 | 0.180 |
Why?
| | Health Status Indicators | 1 | 2016 | 9 | 0.180 |
Why?
| | Vasoconstrictor Agents | 1 | 2016 | 2 | 0.180 |
Why?
| | Weight Loss | 2 | 2008 | 28 | 0.180 |
Why?
| | Pressure | 2 | 2019 | 13 | 0.170 |
Why?
| | Longitudinal Studies | 3 | 2015 | 112 | 0.170 |
Why?
| | Vocal Cord Paralysis | 2 | 2017 | 4 | 0.170 |
Why?
| | Surgicenters | 1 | 2016 | 2 | 0.170 |
Why?
| | Surgical Flaps | 2 | 2019 | 5 | 0.170 |
Why?
| | Models, Organizational | 1 | 2016 | 8 | 0.170 |
Why?
| | Pregnancy | 3 | 2008 | 251 | 0.170 |
Why?
| | Global Health | 1 | 2016 | 12 | 0.170 |
Why?
| | False Negative Reactions | 2 | 2017 | 13 | 0.170 |
Why?
| | Medical Records | 1 | 2016 | 16 | 0.170 |
Why?
| | Volunteers | 1 | 2016 | 3 | 0.170 |
Why?
| | Comprehension | 1 | 2016 | 4 | 0.170 |
Why?
| | Potassium | 1 | 2016 | 12 | 0.170 |
Why?
| | Heparin | 2 | 2013 | 6 | 0.170 |
Why?
| | Granuloma, Plasma Cell | 1 | 2015 | 2 | 0.170 |
Why?
| | Child Health Services | 1 | 2016 | 32 | 0.170 |
Why?
| | Resuscitation | 1 | 2016 | 21 | 0.170 |
Why?
| | Gastric Mucosa | 1 | 2015 | 15 | 0.160 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 4 | 0.160 |
Why?
| | Odds Ratio | 2 | 2012 | 47 | 0.160 |
Why?
| | Fentanyl | 1 | 2015 | 1 | 0.160 |
Why?
| | Hydromorphone | 1 | 2015 | 2 | 0.160 |
Why?
| | Foreign-Body Reaction | 2 | 2007 | 3 | 0.160 |
Why?
| | Pulmonary Blastoma | 1 | 2015 | 1 | 0.160 |
Why?
| | Midazolam | 1 | 2015 | 14 | 0.160 |
Why?
| | Sarcoma, Ewing | 1 | 2015 | 6 | 0.160 |
Why?
| | Esophageal Stenosis | 2 | 2017 | 6 | 0.160 |
Why?
| | Cathartics | 1 | 2015 | 5 | 0.160 |
Why?
| | Canada | 2 | 2012 | 33 | 0.160 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2015 | 1 | 0.160 |
Why?
| | Catheters | 1 | 2015 | 1 | 0.160 |
Why?
| | Remission, Spontaneous | 1 | 2015 | 2 | 0.160 |
Why?
| | Osteosarcoma | 1 | 2015 | 26 | 0.160 |
Why?
| | Ankyrins | 1 | 2014 | 2 | 0.160 |
Why?
| | Gastroplasty | 1 | 2014 | 1 | 0.160 |
Why?
| | Rectal Diseases | 1 | 2014 | 2 | 0.160 |
Why?
| | Benchmarking | 1 | 2014 | 8 | 0.160 |
Why?
| | Acute Chest Syndrome | 1 | 2014 | 3 | 0.160 |
Why?
| | Anemia, Hemolytic, Congenital | 1 | 2014 | 4 | 0.160 |
Why?
| | Antineoplastic Agents | 2 | 2015 | 44 | 0.160 |
Why?
| | Health Services Needs and Demand | 1 | 2014 | 18 | 0.150 |
Why?
| | Advisory Committees | 1 | 2014 | 12 | 0.150 |
Why?
| | Apgar Score | 3 | 2019 | 8 | 0.150 |
Why?
| | Wounds, Penetrating | 1 | 2014 | 4 | 0.150 |
Why?
| | Electric Impedance | 2 | 2012 | 3 | 0.150 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2014 | 2 | 0.150 |
Why?
| | Echocardiography, Transesophageal | 1 | 2014 | 9 | 0.150 |
Why?
| | Pupil | 1 | 2014 | 3 | 0.150 |
Why?
| | Reflex, Pupillary | 1 | 2014 | 3 | 0.150 |
Why?
| | Histological Techniques | 1 | 2014 | 1 | 0.150 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 24 | 0.150 |
Why?
| | Heart | 1 | 2014 | 13 | 0.150 |
Why?
| | Rotation | 2 | 2020 | 5 | 0.150 |
Why?
| | Swine | 3 | 2003 | 18 | 0.150 |
Why?
| | Wound Healing | 2 | 2012 | 8 | 0.150 |
Why?
| | Borderline Personality Disorder | 2 | 1984 | 2 | 0.150 |
Why?
| | Neurotic Disorders | 2 | 1984 | 2 | 0.150 |
Why?
| | Object Attachment | 2 | 1984 | 2 | 0.150 |
Why?
| | Schizophrenic Psychology | 2 | 1984 | 3 | 0.150 |
Why?
| | Personality Disorders | 2 | 1984 | 4 | 0.150 |
Why?
| | Residence Characteristics | 1 | 2014 | 32 | 0.150 |
Why?
| | Burns, Chemical | 1 | 2014 | 1 | 0.150 |
Why?
| | Burns, Electric | 1 | 2014 | 1 | 0.150 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 1 | 0.150 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2014 | 4 | 0.150 |
Why?
| | Seizures | 1 | 2014 | 28 | 0.150 |
Why?
| | Diagnostic Techniques, Digestive System | 2 | 2012 | 5 | 0.150 |
Why?
| | Blood Loss, Surgical | 2 | 2012 | 6 | 0.150 |
Why?
| | Infusions, Intravenous | 2 | 2018 | 26 | 0.150 |
Why?
| | Tissue Donors | 3 | 2002 | 32 | 0.140 |
Why?
| | Solutions | 1 | 2013 | 5 | 0.140 |
Why?
| | Patients | 1 | 2013 | 2 | 0.140 |
Why?
| | Respiratory Tract Infections | 1 | 2014 | 51 | 0.140 |
Why?
| | Hematuria | 1 | 2013 | 4 | 0.140 |
Why?
| | Urinalysis | 1 | 2013 | 9 | 0.140 |
Why?
| | Nephrectomy | 1 | 2013 | 13 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 8 | 0.140 |
Why?
| | Respiratory Sounds | 1 | 2013 | 9 | 0.140 |
Why?
| | Oxycodone | 1 | 2013 | 3 | 0.140 |
Why?
| | Time | 1 | 2013 | 5 | 0.140 |
Why?
| | Cough | 1 | 2013 | 7 | 0.140 |
Why?
| | Appointments and Schedules | 1 | 2013 | 11 | 0.140 |
Why?
| | Symptom Assessment | 1 | 2013 | 9 | 0.140 |
Why?
| | Food | 1 | 2013 | 12 | 0.140 |
Why?
| | Remission Induction | 1 | 2013 | 21 | 0.140 |
Why?
| | Quality Assurance, Health Care | 1 | 2013 | 8 | 0.140 |
Why?
| | Interviews as Topic | 1 | 2013 | 40 | 0.140 |
Why?
| | Fraud | 1 | 2013 | 2 | 0.140 |
Why?
| | Walking | 1 | 2013 | 30 | 0.140 |
Why?
| | Publishing | 1 | 2013 | 9 | 0.140 |
Why?
| | Diet | 1 | 2013 | 39 | 0.140 |
Why?
| | Authorship | 1 | 2013 | 5 | 0.140 |
Why?
| | Venous Cutdown | 1 | 2013 | 1 | 0.140 |
Why?
| | Jugular Veins | 1 | 2013 | 5 | 0.140 |
Why?
| | Risk | 1 | 2013 | 40 | 0.140 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 16 | 0.140 |
Why?
| | Enoxaparin | 1 | 2013 | 3 | 0.140 |
Why?
| | Ileus | 2 | 2009 | 3 | 0.130 |
Why?
| | Organ Specificity | 2 | 2011 | 22 | 0.130 |
Why?
| | Muscle, Smooth | 1 | 2012 | 3 | 0.130 |
Why?
| | Organ Size | 1 | 2012 | 14 | 0.130 |
Why?
| | Ethics, Research | 1 | 2012 | 12 | 0.130 |
Why?
| | Body Size | 1 | 2012 | 9 | 0.130 |
Why?
| | Hospitals, Teaching | 1 | 2012 | 7 | 0.130 |
Why?
| | Polymyxins | 1 | 2012 | 4 | 0.130 |
Why?
| | Wound Infection | 1 | 2012 | 4 | 0.130 |
Why?
| | Administration, Topical | 1 | 2012 | 7 | 0.130 |
Why?
| | Inguinal Canal | 2 | 2015 | 3 | 0.130 |
Why?
| | Ointments | 1 | 2012 | 6 | 0.130 |
Why?
| | Drug Costs | 1 | 2012 | 5 | 0.130 |
Why?
| | Education, Medical | 1 | 2012 | 4 | 0.130 |
Why?
| | Sex Distribution | 2 | 2012 | 19 | 0.130 |
Why?
| | Diarrhea | 1 | 2012 | 12 | 0.130 |
Why?
| | Polytetrafluoroethylene | 1 | 2012 | 1 | 0.130 |
Why?
| | Hypoxia, Brain | 1 | 2012 | 5 | 0.130 |
Why?
| | Uncertainty | 1 | 2012 | 16 | 0.130 |
Why?
| | Ultrasonography, Prenatal | 1 | 2012 | 11 | 0.130 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 33 | 0.130 |
Why?
| | Voice Quality | 1 | 2011 | 2 | 0.130 |
Why?
| | Cerebral Palsy | 1 | 2012 | 11 | 0.130 |
Why?
| | Disease Susceptibility | 1 | 2011 | 8 | 0.130 |
Why?
| | Thoracic Vertebrae | 1 | 2011 | 4 | 0.130 |
Why?
| | Sternum | 1 | 2011 | 6 | 0.130 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 2 | 0.130 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 98 | 0.130 |
Why?
| | Methylprednisolone | 1 | 2011 | 5 | 0.130 |
Why?
| | Spinal Cord Injuries | 1 | 2011 | 4 | 0.130 |
Why?
| | Biomarkers | 1 | 2012 | 117 | 0.120 |
Why?
| | Blister | 1 | 2011 | 2 | 0.120 |
Why?
| | Carbon Dioxide | 1 | 2011 | 11 | 0.120 |
Why?
| | Mediastinal Neoplasms | 1 | 2011 | 3 | 0.120 |
Why?
| | Catheter-Related Infections | 1 | 2011 | 14 | 0.120 |
Why?
| | Wounds, Gunshot | 2 | 2014 | 17 | 0.120 |
Why?
| | Oximetry | 1 | 2011 | 12 | 0.120 |
Why?
| | Personnel Selection | 1 | 2011 | 4 | 0.120 |
Why?
| | Reference Values | 1 | 2011 | 41 | 0.120 |
Why?
| | Colonic Pouches | 1 | 2011 | 1 | 0.120 |
Why?
| | Hand Injuries | 1 | 2011 | 2 | 0.120 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 239 | 0.120 |
Why?
| | Dermatofibrosarcoma | 1 | 2011 | 2 | 0.120 |
Why?
| | Fibrin Tissue Adhesive | 2 | 2008 | 2 | 0.120 |
Why?
| | Early Diagnosis | 1 | 2011 | 33 | 0.120 |
Why?
| | Bacteremia | 1 | 2011 | 26 | 0.120 |
Why?
| | Bronchial Fistula | 2 | 2008 | 3 | 0.120 |
Why?
| | Pneumonectomy | 2 | 2008 | 3 | 0.120 |
Why?
| | Colitis | 1 | 2011 | 7 | 0.120 |
Why?
| | Early Ambulation | 1 | 2011 | 3 | 0.120 |
Why?
| | Skin Neoplasms | 1 | 2011 | 9 | 0.120 |
Why?
| | Journal Impact Factor | 1 | 2010 | 1 | 0.120 |
Why?
| | Bibliometrics | 1 | 2010 | 2 | 0.120 |
Why?
| | Neoadjuvant Therapy | 1 | 2010 | 4 | 0.120 |
Why?
| | Research Support as Topic | 1 | 2010 | 6 | 0.120 |
Why?
| | Research | 1 | 2010 | 13 | 0.120 |
Why?
| | Periodicals as Topic | 1 | 2010 | 7 | 0.120 |
Why?
| | Cross-Cultural Comparison | 1 | 2010 | 6 | 0.120 |
Why?
| | Patient Admission | 1 | 2010 | 7 | 0.120 |
Why?
| | Prosthesis Design | 1 | 2010 | 7 | 0.110 |
Why?
| | Amoxicillin | 1 | 2010 | 7 | 0.110 |
Why?
| | History, 21st Century | 1 | 2010 | 9 | 0.110 |
Why?
| | History, 20th Century | 1 | 2010 | 14 | 0.110 |
Why?
| | Abdominal Neoplasms | 1 | 2010 | 5 | 0.110 |
Why?
| | Coated Materials, Biocompatible | 2 | 2011 | 2 | 0.110 |
Why?
| | Gynecomastia | 1 | 2010 | 2 | 0.110 |
Why?
| | Mastectomy, Subcutaneous | 1 | 2010 | 2 | 0.110 |
Why?
| | Mammaplasty | 1 | 2010 | 2 | 0.110 |
Why?
| | Intestinal Diseases | 1 | 2010 | 5 | 0.110 |
Why?
| | Diphenhydramine | 1 | 2010 | 1 | 0.110 |
Why?
| | Prevalence | 3 | 2017 | 131 | 0.110 |
Why?
| | Intestines | 1 | 2010 | 23 | 0.110 |
Why?
| | Diagnostic Errors | 1 | 2010 | 9 | 0.110 |
Why?
| | Attitude | 1 | 2010 | 17 | 0.110 |
Why?
| | Hydrocephalus | 1 | 2009 | 8 | 0.110 |
Why?
| | Shock, Septic | 1 | 2009 | 2 | 0.110 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2009 | 5 | 0.110 |
Why?
| | Leukemic Infiltration | 1 | 2009 | 5 | 0.110 |
Why?
| | Cystic Fibrosis | 1 | 2009 | 19 | 0.110 |
Why?
| | Infarction | 1 | 2009 | 3 | 0.110 |
Why?
| | Professional Practice | 1 | 2009 | 5 | 0.110 |
Why?
| | Duodenostomy | 1 | 2009 | 2 | 0.110 |
Why?
| | Jejunostomy | 1 | 2009 | 3 | 0.110 |
Why?
| | Evidence-Based Practice | 2 | 2019 | 10 | 0.100 |
Why?
| | Adrenocortical Adenoma | 1 | 2009 | 2 | 0.100 |
Why?
| | Injections, Intralesional | 1 | 2009 | 2 | 0.100 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2009 | 3 | 0.100 |
Why?
| | Hypertension, Renal | 1 | 2009 | 5 | 0.100 |
Why?
| | Reconstructive Surgical Procedures | 2 | 2010 | 10 | 0.100 |
Why?
| | Biliary Tract Diseases | 1 | 2008 | 1 | 0.100 |
Why?
| | Peritoneal Cavity | 1 | 2008 | 3 | 0.100 |
Why?
| | Fecal Impaction | 1 | 2008 | 4 | 0.100 |
Why?
| | Perfusion | 3 | 2003 | 11 | 0.100 |
Why?
| | Dehydration | 1 | 2008 | 2 | 0.100 |
Why?
| | Accidents | 1 | 2008 | 6 | 0.100 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 89 | 0.100 |
Why?
| | Surgical Stapling | 1 | 2008 | 1 | 0.100 |
Why?
| | Goals | 1 | 2008 | 7 | 0.100 |
Why?
| | Infant Food | 1 | 2008 | 9 | 0.100 |
Why?
| | Failure to Thrive | 1 | 2008 | 8 | 0.100 |
Why?
| | Precancerous Conditions | 1 | 2008 | 4 | 0.100 |
Why?
| | Eating | 2 | 2019 | 27 | 0.100 |
Why?
| | Glucocorticoids | 1 | 2009 | 34 | 0.100 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2008 | 6 | 0.100 |
Why?
| | Midwestern United States | 2 | 2019 | 40 | 0.100 |
Why?
| | Duodenoscopy | 1 | 2008 | 3 | 0.100 |
Why?
| | Work Schedule Tolerance | 1 | 2008 | 5 | 0.100 |
Why?
| | Arkansas | 2 | 2019 | 2 | 0.100 |
Why?
| | Oklahoma | 2 | 2019 | 4 | 0.100 |
Why?
| | Arizona | 2 | 2019 | 3 | 0.100 |
Why?
| | Quality of Health Care | 1 | 2008 | 23 | 0.100 |
Why?
| | Texas | 2 | 2019 | 9 | 0.100 |
Why?
| | Cholangiography | 1 | 2008 | 2 | 0.100 |
Why?
| | Cystic Duct | 1 | 2008 | 2 | 0.100 |
Why?
| | Choledocholithiasis | 1 | 2008 | 2 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2008 | 80 | 0.100 |
Why?
| | Disease Progression | 1 | 2008 | 71 | 0.100 |
Why?
| | Consensus | 2 | 2019 | 29 | 0.100 |
Why?
| | Down Syndrome | 1 | 2008 | 25 | 0.100 |
Why?
| | Observation | 1 | 2008 | 3 | 0.100 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2008 | 19 | 0.100 |
Why?
| | Child Abuse | 1 | 2008 | 43 | 0.100 |
Why?
| | Surgical Equipment | 1 | 2007 | 1 | 0.100 |
Why?
| | Rorschach Test | 2 | 1984 | 2 | 0.100 |
Why?
| | Wandering Spleen | 1 | 2007 | 1 | 0.090 |
Why?
| | Cysts | 1 | 2007 | 3 | 0.090 |
Why?
| | Anastomotic Leak | 2 | 2017 | 3 | 0.090 |
Why?
| | Silk | 1 | 2007 | 1 | 0.090 |
Why?
| | Spinal Diseases | 1 | 2007 | 2 | 0.090 |
Why?
| | Urinary Tract | 1 | 2007 | 4 | 0.090 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2007 | 12 | 0.090 |
Why?
| | Mullerian Ducts | 1 | 2006 | 4 | 0.090 |
Why?
| | Uterus | 1 | 2006 | 10 | 0.090 |
Why?
| | Thoracic Injuries | 1 | 2006 | 6 | 0.090 |
Why?
| | In Vitro Techniques | 2 | 2003 | 30 | 0.090 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2006 | 5 | 0.080 |
Why?
| | Relative Value Scales | 1 | 2006 | 3 | 0.080 |
Why?
| | Urachus | 1 | 2005 | 3 | 0.080 |
Why?
| | Urinary Bladder | 1 | 2005 | 5 | 0.080 |
Why?
| | Urethra | 1 | 2005 | 5 | 0.080 |
Why?
| | Cesarean Section | 1 | 2005 | 5 | 0.080 |
Why?
| | Respiration, Artificial | 2 | 2019 | 40 | 0.080 |
Why?
| | Hemolysis | 2 | 2002 | 4 | 0.080 |
Why?
| | Bandages, Hydrocolloid | 1 | 2005 | 1 | 0.080 |
Why?
| | Bilirubin | 2 | 2015 | 15 | 0.080 |
Why?
| | Ischemia | 2 | 2002 | 8 | 0.080 |
Why?
| | Hypospadias | 1 | 2005 | 3 | 0.080 |
Why?
| | Hemoglobins | 2 | 2015 | 23 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2005 | 9 | 0.080 |
Why?
| | Laryngoscopy | 2 | 2017 | 3 | 0.080 |
Why?
| | Dilatation, Pathologic | 1 | 2004 | 6 | 0.080 |
Why?
| | Mitomycin | 1 | 2003 | 1 | 0.070 |
Why?
| | Cisplatin | 1 | 2003 | 7 | 0.070 |
Why?
| | Doxorubicin | 1 | 2003 | 16 | 0.070 |
Why?
| | Allopurinol | 1 | 2003 | 1 | 0.070 |
Why?
| | Raffinose | 1 | 2003 | 1 | 0.070 |
Why?
| | Organ Preservation Solutions | 1 | 2003 | 1 | 0.070 |
Why?
| | Tissue and Organ Harvesting | 1 | 2003 | 2 | 0.070 |
Why?
| | Models, Animal | 1 | 2003 | 7 | 0.070 |
Why?
| | Urea | 1 | 2003 | 12 | 0.070 |
Why?
| | Adenosine | 1 | 2003 | 8 | 0.070 |
Why?
| | Glutathione | 1 | 2003 | 18 | 0.070 |
Why?
| | Osteogenesis | 1 | 2003 | 10 | 0.070 |
Why?
| | Homeostasis | 1 | 2003 | 16 | 0.070 |
Why?
| | Insulin | 1 | 2003 | 44 | 0.070 |
Why?
| | Bile | 1 | 2002 | 16 | 0.070 |
Why?
| | Palliative Care | 2 | 2014 | 40 | 0.070 |
Why?
| | Fatty Liver | 1 | 2002 | 5 | 0.070 |
Why?
| | Hepatocytes | 1 | 2002 | 7 | 0.070 |
Why?
| | Cold Temperature | 1 | 2002 | 3 | 0.070 |
Why?
| | Hot Temperature | 1 | 2002 | 5 | 0.070 |
Why?
| | Hemodynamics | 1 | 2002 | 11 | 0.070 |
Why?
| | Cryopreservation | 1 | 2002 | 4 | 0.060 |
Why?
| | Lipid Metabolism | 1 | 2001 | 8 | 0.060 |
Why?
| | Nausea | 1 | 2020 | 12 | 0.060 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 2 | 0.060 |
Why?
| | Plasma | 1 | 2020 | 9 | 0.060 |
Why?
| | Parenteral Nutrition | 1 | 2019 | 4 | 0.050 |
Why?
| | Infant, Low Birth Weight | 1 | 2019 | 19 | 0.050 |
Why?
| | Age of Onset | 2 | 2013 | 22 | 0.050 |
Why?
| | Dyspnea | 1 | 2019 | 4 | 0.050 |
Why?
| | Shock | 1 | 2019 | 4 | 0.050 |
Why?
| | Prolapse | 1 | 2018 | 4 | 0.050 |
Why?
| | Aorta, Thoracic | 1 | 2018 | 10 | 0.050 |
Why?
| | Preoperative Period | 1 | 2018 | 4 | 0.050 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2018 | 3 | 0.050 |
Why?
| | Program Evaluation | 1 | 2018 | 48 | 0.050 |
Why?
| | Puberty | 1 | 2018 | 6 | 0.050 |
Why?
| | Urinary Tract Infections | 1 | 2018 | 23 | 0.050 |
Why?
| | Biliary Atresia | 1 | 2017 | 4 | 0.050 |
Why?
| | Angiography | 1 | 2017 | 8 | 0.050 |
Why?
| | Infant Care | 1 | 2017 | 7 | 0.050 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2017 | 1 | 0.050 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2017 | 13 | 0.050 |
Why?
| | Clostridium difficile | 1 | 2017 | 8 | 0.050 |
Why?
| | Rare Diseases | 1 | 2017 | 7 | 0.050 |
Why?
| | Tennessee | 1 | 2017 | 2 | 0.050 |
Why?
| | Tracheostomy | 1 | 2017 | 13 | 0.050 |
Why?
| | Parenteral Nutrition, Total | 1 | 2017 | 7 | 0.050 |
Why?
| | Exercise | 1 | 2018 | 96 | 0.050 |
Why?
| | Vancomycin | 1 | 2017 | 17 | 0.050 |
Why?
| | Peritonitis | 1 | 2017 | 49 | 0.050 |
Why?
| | MMPI | 1 | 1996 | 1 | 0.050 |
Why?
| | Personality Development | 1 | 1996 | 1 | 0.050 |
Why?
| | Child of Impaired Parents | 1 | 1996 | 1 | 0.050 |
Why?
| | Asymptomatic Diseases | 1 | 2016 | 6 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2016 | 28 | 0.040 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 79 | 0.040 |
Why?
| | Family | 1 | 1996 | 36 | 0.040 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2015 | 2 | 0.040 |
Why?
| | Ligation | 1 | 2015 | 5 | 0.040 |
Why?
| | Reticulocyte Count | 1 | 2015 | 1 | 0.040 |
Why?
| | Atrophy | 1 | 2015 | 3 | 0.040 |
Why?
| | Reticulocytes | 1 | 2014 | 3 | 0.040 |
Why?
| | Intra-Abdominal Hypertension | 1 | 2014 | 3 | 0.040 |
Why?
| | Thinness | 1 | 2014 | 7 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2014 | 29 | 0.040 |
Why?
| | Hospitals | 1 | 2014 | 19 | 0.040 |
Why?
| | Regional Medical Programs | 1 | 2014 | 1 | 0.040 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 2 | 0.040 |
Why?
| | Anesthesia | 1 | 2014 | 4 | 0.040 |
Why?
| | Kansas | 1 | 2014 | 42 | 0.040 |
Why?
| | Appendiceal Neoplasms | 1 | 2014 | 2 | 0.040 |
Why?
| | Carcinoid Tumor | 1 | 2014 | 2 | 0.040 |
Why?
| | Cecal Diseases | 1 | 2014 | 2 | 0.040 |
Why?
| | Intestinal Neoplasms | 1 | 2014 | 2 | 0.040 |
Why?
| | Enterobiasis | 1 | 2014 | 2 | 0.040 |
Why?
| | Granuloma | 1 | 2014 | 4 | 0.040 |
Why?
| | Electronic Health Records | 1 | 2014 | 47 | 0.040 |
Why?
| | Respiratory Tract Diseases | 1 | 2014 | 9 | 0.040 |
Why?
| | Incidental Findings | 1 | 2014 | 9 | 0.040 |
Why?
| | Multiple Birth Offspring | 1 | 2013 | 3 | 0.040 |
Why?
| | Competitive Behavior | 1 | 2013 | 2 | 0.040 |
Why?
| | Job Application | 1 | 2013 | 2 | 0.040 |
Why?
| | Feces | 1 | 2013 | 31 | 0.030 |
Why?
| | Aptitude | 1 | 1992 | 1 | 0.030 |
Why?
| | Teaching | 1 | 1992 | 6 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2012 | 14 | 0.030 |
Why?
| | Disabled Persons | 1 | 1992 | 6 | 0.030 |
Why?
| | Pleural Cavity | 1 | 2012 | 1 | 0.030 |
Why?
| | Deoxyribonucleases | 1 | 2012 | 2 | 0.030 |
Why?
| | Expectorants | 1 | 2012 | 2 | 0.030 |
Why?
| | Enterostomy | 1 | 2012 | 3 | 0.030 |
Why?
| | Probiotics | 1 | 2012 | 6 | 0.030 |
Why?
| | Pneumonia, Bacterial | 1 | 2012 | 5 | 0.030 |
Why?
| | Temperature | 2 | 2002 | 12 | 0.030 |
Why?
| | Tracheotomy | 1 | 2011 | 2 | 0.030 |
Why?
| | Disinfection | 1 | 2011 | 1 | 0.030 |
Why?
| | Chlorhexidine | 1 | 2011 | 2 | 0.030 |
Why?
| | Povidone-Iodine | 1 | 2011 | 2 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2011 | 6 | 0.030 |
Why?
| | Bandages | 1 | 2011 | 3 | 0.030 |
Why?
| | Anti-Infective Agents, Local | 1 | 2011 | 7 | 0.030 |
Why?
| | Ethanol | 1 | 2011 | 6 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2011 | 4 | 0.030 |
Why?
| | Mediastinum | 1 | 2011 | 5 | 0.030 |
Why?
| | Lymphoma | 1 | 2011 | 7 | 0.030 |
Why?
| | Leukemia | 1 | 2011 | 12 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 2011 | 24 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2011 | 17 | 0.030 |
Why?
| | Foundations | 1 | 2010 | 1 | 0.030 |
Why?
| | United States Public Health Service | 1 | 2010 | 1 | 0.030 |
Why?
| | Committee Membership | 1 | 2010 | 1 | 0.030 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2010 | 4 | 0.030 |
Why?
| | Electronic Mail | 1 | 2010 | 2 | 0.030 |
Why?
| | Financial Support | 1 | 2010 | 2 | 0.030 |
Why?
| | Data Collection | 1 | 2010 | 36 | 0.030 |
Why?
| | Psychometrics | 2 | 1996 | 32 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2010 | 8 | 0.030 |
Why?
| | Gastrointestinal Motility | 1 | 2010 | 7 | 0.030 |
Why?
| | Nipples | 1 | 2010 | 2 | 0.030 |
Why?
| | Diatrizoate Meglumine | 1 | 2009 | 1 | 0.030 |
Why?
| | Hypertrophy | 1 | 2009 | 5 | 0.030 |
Why?
| | Omentum | 1 | 2009 | 4 | 0.030 |
Why?
| | Pneumoperitoneum | 1 | 2009 | 3 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2009 | 26 | 0.030 |
Why?
| | Hamartoma | 1 | 2008 | 4 | 0.030 |
Why?
| | Pregnancy in Diabetics | 1 | 2008 | 2 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 37 | 0.020 |
Why?
| | Esophageal Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Thoracic Neoplasms | 1 | 2008 | 2 | 0.020 |
Why?
| | Respiratory Tract Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Hemothorax | 1 | 2008 | 3 | 0.020 |
Why?
| | Scoliosis | 1 | 2008 | 4 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2008 | 14 | 0.020 |
Why?
| | Aspergillosis | 1 | 2007 | 2 | 0.020 |
Why?
| | Lung Diseases, Fungal | 1 | 2007 | 3 | 0.020 |
Why?
| | Operating Rooms | 1 | 2007 | 4 | 0.020 |
Why?
| | Pharmacy Service, Hospital | 1 | 2007 | 8 | 0.020 |
Why?
| | Emergencies | 1 | 2007 | 13 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2007 | 37 | 0.020 |
Why?
| | Peptostreptococcus | 1 | 2007 | 1 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 1 | 0.020 |
Why?
| | Pelvis | 1 | 2007 | 2 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 150 | 0.020 |
Why?
| | Neoplasms | 1 | 2008 | 87 | 0.020 |
Why?
| | Disorders of Sex Development | 1 | 2006 | 5 | 0.020 |
Why?
| | Urination | 1 | 2005 | 2 | 0.020 |
Why?
| | Diagnostic Tests, Routine | 1 | 2005 | 18 | 0.020 |
Why?
| | Costs and Cost Analysis | 1 | 2005 | 9 | 0.020 |
Why?
| | Health Care Costs | 1 | 2005 | 38 | 0.020 |
Why?
| | Outpatients | 1 | 1984 | 13 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1984 | 15 | 0.020 |
Why?
| | Inpatients | 1 | 1984 | 39 | 0.020 |
Why?
| | Causality | 1 | 2003 | 8 | 0.020 |
Why?
| | Kinetics | 1 | 2002 | 35 | 0.020 |
Why?
| | Hypothermia, Induced | 1 | 2001 | 6 | 0.020 |
Why?
| | Liver Function Tests | 1 | 2001 | 5 | 0.020 |
Why?
| | Psychopathology | 1 | 1996 | 2 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|